Thiazolidinedione use is associated with reduced risk of Parkinson’s disease in patients with diabetes: a meta-analysis of real-world evidence
Salman Hussain, Ambrish Singh, Harveen Baxi, Bruce Taylor, John Burgess, Benny Antony
Topics & Concepts
MedicineThiazolidinedioneMeta-analysisDiabetes mellitusType 2 diabetesInternal medicineHazard ratioPopulationRelative riskConfidence intervalEndocrinologyEnvironmental healthParkinson's Disease Mechanisms and TreatmentsPeroxisome Proliferator-Activated ReceptorsNuclear Receptors and Signaling